REVIEW PAPER
Metabolic disruption in early life: the role of endocrine disruptors in pediatric obesity
1
Department of Forensic Medicine, Medical University of Lublin, Lublin, Poland
2
Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland
Submission date: 2025-06-08
Final revision date: 2025-09-22
Acceptance date: 2025-11-11
Publication date: 2026-03-20
Pediatr Pol 2026;62(1):73-80
KEYWORDS
TOPICS
ABSTRACT
Child and adolescent obesity is a significant and increasingly prevalent public health challenge. Among the contributing factors are endocrine-disrupting chemicals (EDC), which interfere with pathways regulating adipogenesis and metabolic homeostasis. The mechanism of EDC action includes epigenetic modifications, interactions with hormonal receptors, and disruption of key hormones such as leptin, insulin, and thyroid hormones. Exposure during critical developmental periods – specifically in utero and in early childhood – poses a substantial risk, promoting long-term metabolic disorders. This review presents current epidemiological data and discusses potential mechanisms underlying obesity development due to EDC. It also underscores the importance of preventive strategies, including reduced plastic usage, promotion of organic diets, and strengthened regulatory measures, in mitigating the global burden of pediatric obesity.
REFERENCES (45)
1.
Koziol-Kozakowska A, Cichocka-Mroczek E, Wójcik M. Assessment of nutritional status and the occurrence of complications in children with obesity based on its severity. Pediatr Pol 2025; 100: 135-140.
2.
Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol 2022; 10: 351-365.
3.
Molnár D, Mazur A, Gawlik AM, Telega G, Vlachopapadopoulou E, Wojcik M. Editorial: endocrine and metabolic consequences of childhood obesity. Front. Endocrinol 2022; 13: 1000597.
4.
Amato AA, Wheeler HB, Blumberg B. Obesity and endocrine- disrupting chemicals. Endocr 2021; 10: R87-R105.
5.
Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, et al. European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity. Eur J Endocrinol 2020; 182: G1–G32.
6.
Salunke DD, Aher AA, Thitame SN. Endocrine disorder: advance in understanding diabetes and obesity a review. J Pharm Bioallied Sci 2025; 17: S32-S35.
7.
Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M. Endocrine disrupting chemicals: effects on endocrine glands. Front Endocrinol (Lausanne) 2019; 10: 178.
8.
Di Pietro G, Forcucci F, Chiarelli F. Endocrine disruptor chemicals and children’s health. Int J Mol Sci 2023; 24: 2671.
9.
Amir S, Shah STA, Mamoulakis C, Docea AO, Kalantzi OI, Zachariou A, et al. Endocrine disruptors acting on estrogen and androgen pathways cause reproductive disorders through multiple mechanisms: a review. Int J Environ Res Public Health 2021; 18: 1464.
10.
Ahn C, Jeung EB. Endocrine-disrupting chemicals and disease endpoints. Int J Mol Sci 2023;24: 5342.
11.
Guarnotta V, Amodei R, Frasca F, Aversa A, Giordano C. Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. Int J Mol Sci 2022; 23: 5710.
12.
Lizunkova P, Engdahl E, Borbély G, Gennings C, Lindh C, Bornehag CG, et al. A mixture of endocrine disrupting chemicals associated with lower birth weight in children induces adipogenesis and DNA methylation changes in human mesenchymal stem cells. Int J Mol Sci 2022; 23: 2320.
13.
Maradonna F, Carnevali O. Lipid metabolism alteration by endocrine disruptors in animal models: an overview. Front Endocrinol 2018; 9: 654.
14.
Rotondo E, Chiarelli F. Endocrine-disrupting chemicals and insulin resistance in children. Biomedicines 2020; 8: 137.
15.
Celik MN, Yesildemir O. Endocrine disruptors in child obesity and related disorders: early critical windows of exposure. Curr Nutr Rep 2025; 14: 14.
16.
Fassler CS, Pinney SE, Xie C, Biro FM, Pinney SM. Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls. Environ Res 2019; 176: 108558.
17.
Choi YJ, Lee YA, Hong YC, Gho J, Lee KS, Shin CH, et al. Effect of prenatal bisphenol A exposure on early childhood body mass index through epigenetic influence on the insulin-like growth factor 2 receptor (IGF2R) gene. Environ Int 2020; 143: 105929.
18.
Shin MW, Kim SH. Hidden link between endocrine-disrupting chemicals and pediatric obesity. Clin Exp Pediatr 2025; 68: 199-222.
19.
Guarnotta V, Amodei R, Frasca F, Aversa A, Giordano C. Impact of chemical endocrine disruptors and hormone modulators on the endocrine system. Int J Mol Sci 2022; 23: 5710.
20.
Leemans M, Couderq S, Demeneix B, Fini JB. Pesticides with potential thyroid hormone-disrupting effects: a review of recent data. Front Endocrinol (Lausanne) 2019; 10: 743.
21.
Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci 2022; 23: 11899.
22.
Coperchini F, Croce L, Ricci G, Magri F, Rotondi M, Imbriani M, et al. Thyroid disrupting effects of old and new generation PFAS. Front Endocrinol (Lausanne) 2021; 11: 612320.
23.
Yang C, Lee HK, Kong APS, Lim LL, Cai Z, Chung ACK. Early-life exposure to endocrine disrupting chemicals associates with childhood obesity. Ann Pediatr Endocrinol Metab 2018; 23: 182-195.
24.
Nettore IC, Franchini F, Palatucci G, Macchia PE, Ungaro P. Epigenetic mechanisms of endocrine-disrupting chemicals in obesity. Biomedicines 2021; 9: 1716.
25.
Martinho LCAP. Programming of obesity and pediatric metabolic syndromes: a review in light of epigenetic modulation. Int J Nutrol 2021; 15: .
26.
Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci. 2022; 23: 11899.
27.
Dalamaga M, Kounatidis D, Tsilingiris D, Vallianou NG, Karampe- la I, Psallida S, et al. The role of endocrine disruptors bisphenols and phthalates in obesity: current evidence, perspectives and controversies. Int. J Mol Sci 2024; 25: 675.
28.
Lauritzen HB, Larose TL, Øien T, Sandanger TM, Odland JØ, van de Bor M, et al. Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study. Environ Health 2018; 17: 9.
29.
Stratakis N, Rock S, La Merrill MA, Saez M, Robinson O, Fecht D, et al. Prenatal exposure to persistent organic pollutants and childhood obesity: A systematic review and meta-analysis of human studies. Obes Rev 2022; 23: e13383.
30.
Güil-Oumrait N, Stratakis N, Maitre L, Anguita-Ruiz A, Urquiza J, Fabbri L, et al. Prenatal exposure to chemical mixtures and metabolic syndrome risk in children. JAMA Netw Open 2024; 7: e2412040.
31.
Shafei AE, Nabih ES, Shehata KA, Abd Elfatah ESM, Sanad ABA, Marey MY, et al. Prenatal exposure to endocrine disruptors and reprogramming of adipogenesis: an early-life risk factor for childhood obesity. Child Obes 2018; 14: 18-25.
32.
Jerrold J. Heindel, endocrine disruptors and the obesity epidemic. Toxicol Sci 2003; 76: 247-249,.
33.
Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 2017; 68: 3-33.
34.
Heindel JJ, Alvarez JA, Atlas E, Cave MC, Chatzi VL, Collier D, et al. Obesogens and obesity: state-of-the-science and future directions summary from a healthy environment and endocrine disruptors strategies workshop. Am J Clin Nutr 2023; 118: 329-337.
35.
Lv Y, Jia Z, Wang Y, Huang Y, Li C, Chen X, et al. Prenatal EDC exposure, DNA methylation, and early childhood growth: a prospective birth cohort study. Environ Int 2024; 190: 108872.
36.
Le Magueresse-Battistoni B, Labaronne E, Vidal H, Naville D. Endocrine disrupting chemicals in mixture and obesity, diabetes and related metabolic disorders. World J Biol Chem 2017; 8: 108-119.
37.
Gupta R, Kumar P, Fahmi N, Garg B, Dutta S, Sachar S, et al. Endocrine disruption and obesity: a current review on environmental obesogens. Curr Res Green Sustainabl Chem 2020; 3: 100009.
38.
Greenberg P, Chitnis A, Louie D, Simes, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2019). Adv Ther 2023; 40: 4460-4479.
39.
Thomas J. The economic burden of morbid obesity: impact onHealthcare systems. J Obes Weight Loss Ther 2024; 14: 727.
40.
United Nations Environment Programme (UNEP). Global Outlook on Chemicals and Health. UNEP 2021.
41.
Pravednikov A, Perkovic S, Lagerkvist CJ. Main factors influencing the perceived health risk of endocrine-disrupting chemicals: a systematic literature review. Environ Res 2024; 262: 119836.
42.
Mie A, Andersen HR, Gunnarsson S, Kahl J, Kesse-Guyot E, Rembiałkowska E, et al. Human health implications of organic food and organic agriculture: a comprehensive review. Environ Health 2017; 16: 111.
43.
Kassotis CD, Vandenberg LN, Demeneix BA, Porta M, Slama R, Trasande L. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol 2020; 8: 719-730.
44.
Andersson N, Arena M, Auteri D, Barmaz S, Grignard E, Kien- zler A, et al. European Chemical Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint Research Centre (JRC); Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. EFSA J 2018; 16: e05311.
45.
Tickner JA, Simon RV, Jacobs M, Pollard LD, van Bergen SK. The nexus between alternatives assessment and green chemistry: supporting the development and adoption of safer chemicals. Green Chem Lett Rev 2020; 14: 23-44.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
